Formula Pharmaceuticals, Max Delbrueck Center for Molecular Medicine Berlin-Buch deal

Formula and the center partnered to develop cytokine-induced killer (CIK) cell-based chimeric antigen receptor (CAR) immunotherapies using the center’s SB100X transposase gene transfer system. Formula...